title: Warfarin therapy does not increase risk of symptomatic intracerebral hemorrhage in eligible patients after intravenous thrombolysis.
authors.forename: Dimitriy
authors.initials: D
authors.lastname: Levin
authors.forename: Don B
authors.initials: DB
authors.lastname: Smith
authors.forename: Ethan
authors.initials: E
authors.lastname: Cumbler
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Carter
authors.forename: Jeffrey J
authors.initials: JJ
authors.lastname: Glasheen
authors.forename: William
authors.initials: W
authors.lastname: Jones
mesh_terms: D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D007275:Injections, Intravenous; D012307:Risk Factors; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects*; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D014859:Warfarin; D010959:Tissue Plasminogen Activator